Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Isenberg

Showing results (471-480 of 519) with videos related to

Pageof 52
Sort By:
Clinical and Experimental Immunology|February 1, 1991
Detection of human and murine common idiotypes of DNA antibodies in tissues and sera of patients with autoimmune diseasesR A Watts, C T Ravirajan, L S Wilkinson, et al.
Rheumatology (Oxford, England)|February 2, 2008
SLE patients with renal damage incur higher health care costsA E Clarke, P Panopalis, M Petri, et al.
Journal of Autoimmunity|December 1, 1991
Abnormalities in the glycosylation of IgG in spouses of patients with rheumatoid arthritis. A family studyN Sumar, C B Colaço, K B Bodman, et al.
Autoimmunity|January 1, 1992
Analysis of antibody reactivity in the sera of 42 patients with paraproteinaemiaA J MacGregor, J Kalsi, C T Ravirajan, et al.
Journal of Autoimmunity|February 1, 1997
The production, binding characteristics and sequence analysis of four human IgG monoclonal antiphospholipid antibodiesS Menon, M A Rahman, C T Ravirajan, et al.
Rheumatology (Oxford, England)|October 18, 2000
Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigenG Frampton, S Moriya, J D Pearson, et al.
Annals of the Rheumatic Diseases|December 1, 1983
The use of C3d as a means of monitoring clinical activity in systemic lupus erythematosus and rheumatoid arthritisW J Morrow, D J Williams, C Ferec, et al.
The Quarterly Journal of Medicine|November 1, 1988
Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG)D P Symmons, J S Coppock, P A Bacon, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled studyD A Isenberg, M Petri, K Kalunian, et al.
QJM : Monthly Journal of the Association of Physicians|October 1, 1994
C3 nephritic factor and SLE: report of four cases and review of the literatureM J Walport, K A Davies, M Botto, et al.
Pageof 52

Showing results (471-480 of 519) with videos related to

Sort By:
Pageof 52
Clinical and Experimental Immunology|February 1, 1991
Detection of human and murine common idiotypes of DNA antibodies in tissues and sera of patients with autoimmune diseasesR A Watts, C T Ravirajan, L S Wilkinson, et al.
Rheumatology (Oxford, England)|February 2, 2008
SLE patients with renal damage incur higher health care costsA E Clarke, P Panopalis, M Petri, et al.
Journal of Autoimmunity|December 1, 1991
Abnormalities in the glycosylation of IgG in spouses of patients with rheumatoid arthritis. A family studyN Sumar, C B Colaço, K B Bodman, et al.
Autoimmunity|January 1, 1992
Analysis of antibody reactivity in the sera of 42 patients with paraproteinaemiaA J MacGregor, J Kalsi, C T Ravirajan, et al.
Journal of Autoimmunity|February 1, 1997
The production, binding characteristics and sequence analysis of four human IgG monoclonal antiphospholipid antibodiesS Menon, M A Rahman, C T Ravirajan, et al.
Rheumatology (Oxford, England)|October 18, 2000
Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigenG Frampton, S Moriya, J D Pearson, et al.
Annals of the Rheumatic Diseases|December 1, 1983
The use of C3d as a means of monitoring clinical activity in systemic lupus erythematosus and rheumatoid arthritisW J Morrow, D J Williams, C Ferec, et al.
The Quarterly Journal of Medicine|November 1, 1988
Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG)D P Symmons, J S Coppock, P A Bacon, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled studyD A Isenberg, M Petri, K Kalunian, et al.
QJM : Monthly Journal of the Association of Physicians|October 1, 1994
C3 nephritic factor and SLE: report of four cases and review of the literatureM J Walport, K A Davies, M Botto, et al.
Pageof 52